about
Statin intolerance - a question of definition.Common and rare variants associating with serum levels of creatine kinase and lactate dehydrogenase.Association of rosuvastatin and delirium in severe sepsis with acute respiratory distress syndromeEfficacy of low- and moderate-intensity statins for achieving low- density lipoprotein cholesterol targets in Thai type 2 diabetic patients.Statins and Cataracts--a visual insight.Primary prevention of atherosclerotic cardiovascular disease: controversies and clinical considerations.Current drug treatment of hyperlipidemia in older adults.Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies.Evaluation of the Potential Role of Alirocumab in the Management of Hypercholesterolemia in Patients with High-Risk Cardiovascular Disease.Current Controversies With Recent Cholesterol Treatment Guidelines.Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.Gemfibrozil in Combination with Statins-Is It Really Contraindicated?Approach to Statin Use in 2016: an Update.Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study.Beta-2 Agonism: A Potential Therapeutic Target for DyslipidemiaSimvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database.A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury.A common missense variant of LILRB5 is associated with statin intolerance and myalgia.Incorporation of PCSK9 inhibitors into prevention of atherosclerotic cardiovascular disease.Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care.
P2860
Q30245218-2A531F03-71A0-4759-BC96-72E9E59418D3Q36548818-CA27510B-B98F-4D6B-852E-738511316365Q37208745-6BFDEB48-ECC8-4082-BA3C-F61913FB9126Q37640762-9DDB423E-4924-4746-93F0-1B3E6ACE984BQ38285483-F0720D90-77F7-40FC-9B3C-48851A6DE902Q38295069-2820B7A9-7DE0-4FFE-BD02-3781116CAB4EQ38338437-C6E0832A-AC42-488E-8516-B928DC19CC58Q38538716-B57FBC7C-0F5D-4D79-BE58-B47B87544809Q38563329-775F7B81-F634-4888-B47D-89970564C6F3Q38649661-F0836C40-68D3-446D-B956-70060FD396DFQ38723341-4E9008A1-2168-47B6-B505-D6ABDBB60A09Q38756974-6C855980-EC17-4531-BC7D-F598961B2C6AQ38773373-C7FECA97-1098-407E-B691-2610E32E48E6Q39238333-101C8635-68FF-47E6-A0D0-153E2A1BCAEBQ39796563-1C362778-C4E8-4CE5-9976-9D949B4B30E0Q41581435-DDDDCFC5-3364-46CE-B74B-FE00222BE7E4Q44137319-8A6B1B96-D8CF-4E77-AC65-A3D53FA018E7Q47096819-46D396C9-F937-4600-8CBC-573ED365AD49Q47747535-5291885E-9601-4574-AE5E-55E54EFC73F2Q47844045-045DB78E-1402-4D40-B9C1-A066A683E3B3Q52804432-98F3EEC4-1BEC-4C52-8A06-E633424B8B45
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
NLA Task Force on Statin Safety--2014 update.
@en
NLA Task Force on Statin Safety--2014 update.
@nl
type
label
NLA Task Force on Statin Safety--2014 update.
@en
NLA Task Force on Statin Safety--2014 update.
@nl
prefLabel
NLA Task Force on Statin Safety--2014 update.
@en
NLA Task Force on Statin Safety--2014 update.
@nl
P1476
NLA Task Force on Statin Safety--2014 update.
@en
P356
10.1016/J.JACL.2014.03.003
P407
P433
P577
2014-05-01T00:00:00Z